The short version of secretagogue fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-13 and is reviewed periodically as new material appears.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
Quality claims for research peptides vary widely across suppliers. A certificate of analysis should list purity by chromatography, the mass found by spectrometry, and the analytical conditions used. Independent testing at a third-party laboratory is a common way to check identity and purity, because documents alone cannot confirm what is inside a vial. Purity figures describe the proportion of the target peptide among detected species, and they say nothing about biological activity or sterility.
Lyophilized ipamorelin powder is the form usually supplied for laboratory work. Kept dry, protected from light, and held at minus 20 degrees Celsius or below, it remains stable for extended periods, often measured in years. Once dissolved, the peptide degrades faster through hydrolysis, oxidation, and deamidation, so solutions are typically refrigerated and used within weeks. Repeated freeze-thaw cycles and exposure to alkaline conditions accelerate loss of the parent compound.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentapeptide | Chain of five amino acid residues |
| Molecular mass | Approximately 712 Da | Consistent with a five-residue chain |
| Receptor target | GHS-R1a | Growth hormone secretagogue receptor |
| Primary action | Growth hormone release | Pituitary somatotroph stimulation |
| Research origin | Developed in the 1990s | Small-peptide secretagogue program |
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.
Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.
== Major leagues == Epstein was first brought up for six games by the Baltimore Orioles in 1966, at the age of 23. After the Orioles tried in vain to convert him to the outfield (they already had Boog Powell at first base), they demoted him to Rochester again. The outspoken Epstein refused to report, going home to California and continuing his schooling instead. He was traded along with Frank Bertaina from the Orioles to the Washington Senators for Pete Richert on 29 May 1967, going from one of the best organizations in baseball to one of the worst. Later that season, in his first at-bat against the Orioles, Epstein hit a grand slam. In 1968 he was fourth in the league in getting hit by pitches HBP (9). In 1969 with the Senators, in only 403 at bats Epstein hit 30 home runs (ninth in the American League), had 85 runs batted in (RBIs), and hit for a .278 batting average (and .347 with runners in scoring position) with an excellent .414 on-base percentage and .551 slugging percentage. He was fourth in the league in hit by pitch (10), and he hit a home run every 13.4 at bats. He was 25th in voting for the American League MVP. This was also the only year in which the reconstituted Senators (now the Texas Rangers) finished above .500. In 1970, he was second in the league in being hit by a pitch (13), while hitting 20 home runs, and leading all AL first basemen in range factor (10.08). In 1969-70, he was managed by Hall of Fame hitting great Ted Williams.
The evidence for this stems from the different binding profiles of typical mu and delta agonists such as morphine and DAMGO respectively, in cells that coexpress both receptors compared to those in cells that express them individually. In addition, work by Fan and coworkers shows the restoration of the binding profiles when distal carboxyl termini are truncated at either receptor, suggesting that the termini play a role in the oligomerization. While this is exciting, rebuttal by the Javitch and coworkers suggest the idea of oligomerization may be overplayed. Relying on RET, Javitch and coworkers showed that RET signals were more characteristic of random proximity between receptors, rather than an actual bond formation between receptors, suggesting that discrepancies in binding profiles may be the result of downstream interactions, rather than novel effects due to oligomerization. Nevertheless, coexpression of receptors remains unique and potentially useful in the treatment of mood disorders and pain. Recent work indicates that exogenous ligands that activate the delta receptors mimic the phenomenon known as ischemic preconditioning. Experimentally, if short periods of transient ischemia are induced the downstream tissues are robustly protected if longer-duration interruption of the blood supply is then effected. Opiates and opioids with DOR activity mimic this effect. In the rat model, introduction of DOR ligands results in significant cardioprotection.
As for second-hand smoke, the NIH study points to the large amount of smoke generated by one cigar, saying "cigars can contribute substantial amounts of tobacco smoke to the indoor environment; and, when large numbers of cigar smokers congregate in a cigar smoking event, the amount of passive smoke produced is sufficient to be a health concern for those regularly required to work in those environments". Smoking also tends to increase blood cholesterol levels. Furthermore, the ratio of high-density lipoprotein (HDL, commonly referred to as "good" cholesterol) to low-density lipoprotein (LDL, "bad" cholesterol) tends to be lower in smokers compared to non-smokers. Smoking also raises the levels of fibrinogen and increases platelet production (both involved in blood clotting), which makes the blood thicker and more likely to clot. Carbon monoxide binds to hemoglobin (the component carrying the oxygen in red blood cells), resulting in a much more stable complex than hemoglobin bound with oxygen or carbon dioxide and therefore permanent loss of blood cell functionality. Blood cells are naturally recycled after a certain period, allowing for the creation of new, functional red blood cells. However, if carbon monoxide exposure reaches a certain point before it can be recycled, hypoxia (and later death) occurs. All these factors make smokers more at risk of developing various forms of arteriosclerosis (hardening of the arteries).
=== 2 April === Russian military blogger Vladlen Tatarsky was killed by an explosion in a cafe in St Petersburg. The explosion injured around 24 people of which 6 were in critical condition. The cafe where the explosion occurred belongs to Yevgeny Prigozhin. Armenia said that it won't arrest Putin despite the country trying to join the International Criminal Court. This is after the Kremlin threatened "serious negative consequences" and the banning of Armenian dairy products. The Deputy Speaker of the Armenian Parliament Hakob Arshakyan said: "The decision of the constitutional court does not find anyone guilty in any matter and does not require steps to arrest anyone...We have heard concerns expressed by the Russian Federation."
=== Medical === Puffballs are a known styptic and have long been used as wound dressing, either in powdered form or as slices 3 cm thick. Authors Hui-Yeng Y. Yap, Mohammad Farhan Ariffeen Rosli, et al. found evidence to suggest that C. gigantea was "traditionally used by American Indians, Nigerian and German folks" for this purpose. The authors, however, did not specify the preferred form of wound dressing (e.g., powdered or sliced). In addition to consuming the mushroom, the Māori people of New Zealand used it to stem bleeding and treat burns.
Sources: en.wikipedia.org
The condensation of N-(2-fluoro-6-(trifluoromethyl)benzyl)urea [830346-46-8] (1) with t-butyl acetoacetate [1694-31-1] under acidic conditions to generate the 6-methyluracil derivative, [830346-47-9] (2). Halogenation using iodine monochloride provided [1150560-54-5] (3). Suzuki coupling with 2-fluoro-3-methoxyphenylboronic acid [352303-67-4] (4) gave [1150560-59-0] (5). The catalyst used for this step was PdCl2(dtbpf). FGI of N-Boc-2-phenyl-D-glycinol [102089-74-7] (6) to the mesylate, [102089-75-8] (7) was followed by alkylation and alkaloine hydrolysis of the Boc protecting group to give [830346-50-4] (8). Alkylation of the primary amine with ethyl 4-bromobutyrate [2969-81-5] (9) gave ester [832720-84-0] (10). Saponification of the ester in alcoholic lye completed the synthesis of elagolix sodium (11).
=== ESG after surgical sleeve gastrectomy (Revisional ESG) === Weight regain after surgical sleeve gastrectomy has historically been managed with medications or a more invasive revisional surgery. Recent data suggested that an ESG can safely be performed after the surgical sleeve gastrectomy (sometimes referred to as a "revisional ESG"), with total body weight loss of approximately 16-18% at 12 months. While weight loss is not thought to be as robust as the initial weight loss surgery, the revisional ESG has an improved safety profile compared to a surgical revision and is therefore hypothesized to have greater patient acceptance.
Following the ("scientific", rather than "industrial") discoveries, insights, and experimental advances from Banting and Best's experiments with "diabetic dogs", the combined efforts of the Department's head, John Macleod (a former assistant to Robertson), its pharmacology lecturer, Banting, "a battlefield surgeon with minimal research experience", and former general practitioner from London, Ontario, assisted by both Macleod's undergraduate student, Best, and the biochemist, James Collip, Assistant Professor of Biochemistry at University of Alberta, at Toronto under a Rockefeller Travelling Fellowship (not added to the team until December 1921) — who not only had considerable research experience with "internal secretions, but also had considerable experience in making and administering tissue extracts" — culminated in the successful (23 January 1922) first-ever life-saving treatment of diabetes mellitus (now known as Type 1 diabetes) when the extract that Collip had isolated, extracted, and refined from cattle pancreases (i.e., refined by Collip to the extent that the team believed a human could tolerate) was injected into the almost moribund 13-year-old Leonard Thompson in the Toronto General Hospital. The pancreatic extract injected into Thompson's buttocks was "a murky, light-brown liquid containing much sediment, which dissolved to a considerable extent on being warmed" (WC.1, p.68). Thompson lived for another 13 years; he died, aged 27, of bronchopneumonia. In the view of the Tufts' Professor of Clinical Medicine, Joseph H.
== Personal life == Findlay was married to lawyer A. Boyd Ferris, with whom she had two children. After Ferris died from a heart attack in 1989, she met actor Brent Chapman. The two married in 1993 and had two more daughters together; they also have nine grandchildren. Chapman was elected as the provincial MLA for Surrey South in the 2024 British Columbia general election. Findlay is a member of the All-Saints Community Church in White Rock, British Columbia, which is part of the Anglican Mission in the Americas, through its Canadian branch. Findlay's volunteer posts, in addition to the Canadian Bar Association, have included chair of the Vancouver City Planning Commission, board member of Science World, executive member of the Junior Leagues of Canada, president of Delta Zeta chapter of Alpha Gamma Delta International Fraternity, and honorary counsel for the Chinese Benevolent Association of Canada. In 2016, she was named a Distinguished Citizen by Alpha Gamma Delta. In 2001, she declared bankruptcy with more than a half million dollars in debt. She attributed the bankruptcy to a legal battle with the Musqueam First Nation.
==== Kidneys ==== Renal amyloidosis can occur as a consequence of untreated chronic inflammation. Treatment with penicillamine or gold salts such as sodium aurothiomalate are recognized causes of membranous nephropathy.
Sources: en.wikipedia.org
It acts on the growth hormone secretagogue receptor, GHS-R1a, which is also the receptor for ghrelin. Binding triggers intracellular signaling that promotes growth hormone release from the pituitary. The interaction is the basis for its classification as a secretagogue.
In animal studies it showed greater selectivity for growth hormone release, with less effect on cortisol and adrenocorticotropic hormone than compounds such as GHRP-6. This selectivity is one of the most frequently cited features in preclinical literature. Whether the same profile applies in other contexts is not fully established.
The receptor-level events are reasonably well described, but the full range of downstream effects is not. Studies have reported activity in tissues beyond the pituitary, including the gut. How these observations translate across species and conditions remains an open question.
Keep the powder dry, protected from light, and at minus 20 degrees Celsius or lower. A desiccant and a sealed vial limit moisture uptake. Let the vial reach room temperature before opening to reduce condensation.